As federal agencies begin to receive American Recovery and Reinvestment Act (ARRA) funds (see IBO 2/28/09)—the so-called US stimulus funding—they are releasing more information about how they plan to spend the money. Of all of the agencies, the NIH was the largest beneficiary (see IBO 2/28/09) of ARRA funds for research. This article will outline […]
Product Introductions Bruker BioSpin introduced the QCI CryoProbe, a proton-optimized quadruple resonance NMR inverse probe for structural biology applications involving proteins, RNA and DNA. Bruker BioSpin released the 500 MHz BBFOplus SmartProbe for routine small-molecule NMR. Bruker BioSpin launched the 900 MHz WB US2, calling it the world’s highest field, actively shielded wide bore 89 […]
The IBO Laboratory Sales Index has been updated from the February 15 issue now that 19 of the 21 companies in the Index have reported calendar-year 2008 results. Estimates are provided for Oxford Instruments and Shimadzu. For the fourth quarter, Laboratory Sales Index revenues improved 1.1% to $4,715 million. Operating profits grew 2.4%, and operating […]
FoodProcessing.com estimates that capital spending by the top 20, publicly held, US food and beverage companies will decline 2.9% this year. Eleven of the 20 firms plan to increase capital spending in 2009. In some cases, the companies are planning to do so because of acquisitions, including Ralcorp and J.M. Smucker. Of the 11 companies […]
Longjumeau, France 4/20/09—Horiba Jobin Yvon has acquired GenOptics, a provider of surface plasmon resonance imaging technology (SPRi) for label-free detection for an undisclosed amount. “In the coming years we will see the merging of biotechnology and microtechnology to create combinations of ultra integrated devices on a molecular scale” stated Dr. Michel Mariton, HORIBA Scientific segment […]
Waltham, MA 4/22/09—Phase Forward, a supplier of clinical trials software, has acquired Waban Software for $14 million in cash. Waban’s products include clinical data analysis systems, as well as lab information and clinical specimen management systems. In 2008, Waban had $4 million in revenues and break even operating income. Based in Cambridge, Massachusetts, with operations […]
Newark, CA 4/23/09; Paris, France 4/24/09—GE has signed a definitive agreement to sell an 81% stake in GE Security’s Homeland Protection business to high-technology firm SAFRAN for $580 million. GE will retain a 19% stake. GE’s Homeland Protection business consists of products for checked-baggage screening, military and critical infrastructure protection, as well as products for […]
Waltham, MA 4/27/09; Sydney, Australia 4/27/09—Thermo Fisher Scientific has agreed to acquire Biolab, a laboratory products distributor for the scientific, environment and healthcare markets in Australia and New Zealand. Thermo will acquire the business from Australian conglomerate Alesco for AUD $175 million ($120 million). Biolab has annual revenues of AUD $170 ($120 million). “As the […]
IMS Health forecasts the global pharmaceutical market to grow 2.5%–3.5% in 2009, excluding currency effects, to more than $750 billion. This is down from the previous estimate of 4.5%–5.5% growth (see IBO 10/31/08). Compound annual growth for 2009 through 2013 is estimated to be 3%–6%. IMS observed that consumers are less likely to start new […]
Company Announcements STARLIMS Technologies’ 2008 sales rose 6.2% to $25.2 million (see IBO 3/31/09). Product revenue grew 11.3% to $15.5 million, and Service revenue declined 1.1% to $9.8 million. Adjusted operating income fell 30.2% to $3.0 million. Sales to public-sector labs accounted for 39% of revenues, manufacturing customers accounted for 25% of sales. Revenue from […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
